WisdomTree was founded in 2006 with a passion for creating better ways to index, innovate and invest for our clients, and by being the first investment manager to weight by dividends. We have always challenged the status quo and believe investors should too.
Since launching in Europe in 2014, our European business has grown in terms of our product range and assets under management. Today, we provide one of the most innovative ranges of UCITS Exchange Traded Funds (ETFs) and Exchange Traded Products (ETPs) covering commodities, FX, equities, fixed income, digital assets and liquid alternatives as well as short & leveraged exposures.
Nvidia recently reported its earnings, showcasing strong performance, but it failed to meet the market's high expectations. Despite beating analyst forecasts, the stock faced a sharp sell-off as investors reassessed the company's future growth prospects.
When constructing our Biorevolution strategy, we worked alongside futurist Dr Jamie Metzl, who is a member of the World Health Organization’s expert committee on human genome editing. We believe that we are on the precipice of a remarkable period,
Plenty of deals are happening in the world of tech startups, but two stories stand out, offering three important lessons for investors. The first story is about Google's parent Alphabet, which was considering a $23 billion acquisition of the cybersecurity startup Wiz.
